A novel system for the evaluation of the activity and/or specificity of a viral component
US2002061297A1
Novel recombinant DNA vectors for gene therapy
AU2799400A
Multiplex real-time pcr
WO0017374A1
Retroviral particles protected against complement mediated destruction
WO0012737A1
Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
AU4903099A
Targeted integration into chromosomes using retroviral vectors
WO9940219A1
Quantification by inhibition of amplification
WO9935280A1
Reconstituting retroviral vector (recon vector) for targeted gene expression
EP1021545A2
Dengue virus antigens and treatment of dengue fever
EP0994965A2
Taqman?tm -pcr for the detection of pathogenic e. coli strains
WO9827966A2
Encapsulated cells producing antibodies
US6117681A
Pseudotyped retroviral particles
EP0951555A2
Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
WO9630533A1
Pseudotyped retroviral particles
WO9628564A1
Novel recombinant dna vectors for gene therapy
AU5103996A
Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
